What is the primary purpose of these Bylaws amendments?

The primary purpose of these amendments is to modernize Edwards Lifesciences' corporate governance, particularly in the areas of stockholder meetings and communications, and to streamline certain legal and administrative processes. This includes adopting more flexible virtual meeting capabilities and clarifying advance notice and litigation forum provisions.

How do these changes affect my ability to participate in stockholder meetings?

The amendments enhance your ability to participate by allowing the company to hold meetings entirely via remote communication (virtual meetings). Additionally, notices and proxy delivery can be made electronically, making it easier to receive information and cast your vote, regardless of your physical location.

What is the significance of the exclusive forum provision for Securities Act of 1933 litigation?

This provision designates U.S. federal district courts as the exclusive venue for any lawsuits related to the Securities Act of 1933. For investors, this means that any such litigation must be filed in federal court, which can lead to more consistent application of securities laws and potentially more efficient resolution of disputes.

Are there any changes regarding who can nominate directors?

Yes, the Bylaws were amended to clarify that only stockholders of record are eligible to nominate directors for election at meetings through the advance notice provisions. This ensures that nomination rights are held by those with a direct ownership stake in the company.

EW 8-K: Corporate Changes

Summary

Edwards Lifesciences Corporation (EW) filed an 8-K on July 15, 2021, to announce amendments to its corporate Bylaws. These changes primarily focus on modernizing meeting procedures and clarifying governance provisions. Key updates include enabling virtual stockholder meetings and electronic delivery of notices and proxies, aligning with recent Delaware law amendments. This offers greater flexibility and accessibility for shareholder participation and communication. Further enhancements address director nominations, allowing only stockholders of record to nominate candidates and clarifying the maximum number of nominees. The Bylaws also refine procedures for meeting adjournments and the signing of stock certificates. Notably, a new exclusive forum provision designates U.S. federal district courts for Securities Act of 1933 litigation, aiming to streamline legal proceedings. These amendments are designed to improve operational efficiency and corporate governance for the company.

Key Highlights

1Edwards Lifesciences amended and restated its Bylaws as of July 15, 2021.
2The company can now hold stockholder meetings entirely by remote communication (virtual meetings).
3Provisions for electronic delivery of stockholder notices and proxies have been clarified and expanded.
4Amendments clarify advance notice provisions for director nominations, including eligibility for stockholders of record.
5Procedures for adjourning meetings with less than a quorum have been refined.
6The Bylaws now permit any two authorized officers to sign stock certificates.
7A new provision designates U.S. federal district courts as the exclusive forum for Securities Act of 1933 litigation.

Edwards Lifesciences Corp 8-K Report, Bylaw Amendment (Jul 15, 2021)

Summary

Key Highlights

Frequently Asked Questions